Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL
Author:
Affiliation:
1. Hematology Branch, National Heart, Lung and Blood Institute and
2. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and
3. Pharmacyclics Inc., Sunnyvale, CA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/123/21/3286/1377498/3286.pdf
Reference50 articles.
1. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.;Herishanu;Blood,2011
2. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia.;Burger,2011
3. Chronic lymphocytic leukemia.;Chiorazzi;N Engl J Med,2005
4. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.;Messmer;J Clin Invest,2005
5. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.;Rossi;Blood,2013
Cited by 201 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy;Cancer Letters;2024-02
2. Synergistic Inhibition of Burkitt’s Lymphoma with Combined Ibrutinib and Lapatinib Treatment;Korean Journal of Clinical Laboratory Science;2023-12-31
3. CXCR4-BTK axis mediate pyroptosis and lipid peroxidation in early brain injury after subarachnoid hemorrhage via NLRP3 inflammasome and NF-κB pathway;Redox Biology;2023-12
4. Biological, prognostic, and therapeutic impact of the epigenome in CLL;Seminars in Hematology;2023-12
5. Obinutuzumab‐Based Drug‐Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors;Macromolecular Bioscience;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3